Research Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry…
General Information Congress Venue Meliá Castilla Calle del Capitán Haya, 43 Madrid 28020 Spain Climate and Dress Code Madrid and its metropolitan area has a Mediterranean climate with continental…
Louis-Philippe Boulet Asthma Research and Practice 2016 2:3 DOI: 10.1186/s40733-015-0015-1 Abstract Asthma affects a significant proportion of elderly patients, but unfortunately, it is responsible for a high asthma-related morbidity and mortality in this…
Significant achievements have been accomplished in the last few years to better understanding what is asthma, how it should be assessed in regard to control and severity and what is…
Saturday March 12 | Room A Room B Room C 14.30 ACOS Symposium Chairs: Stefano Centanni, Joan Soriano Marc Miravitlles “ACOS-The Spanish document”Vito Brusasco “Do we need ACOS?” Mar Fernandez- Nieto “Eosinophilic bronchitis”…
Asthma Research and Practice2016 2:2 DOI: 10.1186/s40733-015-0018-y Alida Benfante and Nicola Scichilone Abstract Historically, asthma has been envisioned as a disease of younger ages. This has led to the assumption that respiratory symptoms suggestive of…
Asthma Research and Practice 2016 2:1 DOI: 10.1186/s40733-015-0019-x Abstract Background In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of…
REVIEW Carlo Lombardi, Giovanni Passalacqua and Giorgio Walter Canonica Asthma Research and Practice 201 51:15 DOI: 10.1186/s40733-015-0017-z Abstract Globally, an estimated 300 million people have asthma, presenting a considerable and increasing burden of disease for healthcare systems, families,…
REVIEW Robyn T. Cohen, Elizabeth S. Klings and Robert C. Strunk Asthma Research and Practice20151:14 DOI: 10.1186/s40733-015-0014-2 Abstract Sickle cell disease (SCD) is the most common life-limiting genetic disease among African Americans, affecting more than 100,000 people in the…